The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

TRDA FINANCIAL STATEMENTS

Entrada Therapeutics Inc — balance sheet, income statement and cash flow trends

TRDAEntrada Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M202020212022202320252026

Profit Funnel

Q2 2026 · TTM
Revenue4.7 M $Gross Profit-35.4 M $ · -755%Operating Income-176.5 M $ · -3767%Pre-tax Income-165 M $ · -3520%Net Income to Owners-165.8 M $ · -3538%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue4.7 M $-94.1%
Gross Profit-35.4 M $-144.5%
Operating Income-176.5 M $—
EBITDA-164.9 M $—
Net Income to Owners-165.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202020212022202320252026

Capital Structure

Q2 2026
Total Assets298.9 M
  • Equity233.4 M $78%
  • Current Liabilities21.4 M $7%
  • Long-term Liabilities44.1 M $15%

Key Figures

YoY change
Total Assets298.9 M $-33.4%
Total Liabilities65.5 M $-5.5%
Total Equity233.4 M $-38.5%
Cash & ST Investments223 M $-37.0%
Total Debt48.5 M $-11.3%
Net Debt-50.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0100 M202020212022202320252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M0-134.7 M $Operating160.2 M $Investing650 K $Financing26.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-134.7 M $—
Capital Expenditures433 K $-83.9%
Free Cash Flow-134.4 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TRDA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.